{"text_format":"3","workbook":"xlsx","n_sheets":1,"sheets":["Supplementary_TableS7_RNA-pathw"],"read":"whole","date_system":"1900"}

{"sheet":"Supplementary_TableS7_RNA-pathw","index":0,"n_rows":114,"n_cols":7,"rows_kept":114}
["no.","Name","Total","Hits","EnrichmentScore","Pval","Padj"]
[1,"Calcium signaling pathway",68,58,-0.3704283,0.00016852,0.002783901]
[2,"Vascular smooth muscle contraction",30,22,-0.438199017,1.72831E-4,0.002783901]
[3,"Linoleic acid metabolism",30,26,-0.601199479,0.000182615,0.002783901]
[4,"Ascorbate and aldarate metabolism",34,28,-0.671750832,1.84468E-4,0.002783901]
[5,"Chronic myeloid leukemia",33,27,0.525077061,0.000224266,0.002783901]
[6,"p53 signaling pathway",31,27,0.496607465,2.27894E-4,0.002783901]
[7,"Spliceosome",27,22,0.528907446,0.000228728,0.002783901]
[8,"AGE-RAGE signaling pathway in diabetic complications",18,16,0.469492407,2.3116E-4,0.002783901]
[9,"Ubiquitin mediated proteolysis",27,25,0.47234138,2.33372E-4,0.002783901]
[10,"Osteoclast differentiation",44,39,0.498255533,2.34522E-4,0.002783901]
[11,"Systemic lupus erythematosus",19,19,0.445431915,2.34522E-4,0.002783901]
[12,"Natural killer cell mediated cytotoxicity",17,16,0.457981902,0.000234962,0.002783901]
[13,"Ribosome",60,54,0.464454715,0.00023596,0.002783901]
[14,"Protein processing in endoplasmic reticulum",133,103,0.435434719,0.000237869,0.002783901]
[15,"Phagosome",21,20,0.430044907,2.3912E-4,0.002783901]
[16,"Hepatitis B",130,109,0.396022317,2.39578E-4,0.002783901]
[17,"Cellular senescence",57,41,0.429976835,0.000242424,0.002783901]
[18,"Hippo signaling pathway",36,33,0.397656035,0.000242424,0.002783901]
[19,"Tuberculosis",40,36,0.375195692,2.42895E-4,0.002783901]
[20,"Epstein-Barr virus infection",47,44,0.378657096,2.42895E-4,0.002783901]
[21,"Kaposi's sarcoma-associated herpesvirus infection",48,39,0.416256435,0.000243132,0.002783901]
[22,"Transcriptional misregulation in cancer",59,44,0.432770926,0.000243132,0.002783901]
[23,"Viral carcinogenesis",50,45,0.460146515,2.43191E-4,0.002783901]
[24,"Proteoglycans in cancer",23,22,0.381943862,2.43902E-4,0.002783901]
[25,"HTLV-I infection",36,34,0.392220339,0.000245942,0.002783901]
[26,"Endocytosis",17,17,0.40770066,0.000247036,0.002783901]
[27,"PI3K-Akt signaling pathway",42,37,0.325070323,2.65111E-4,0.002876949]
[28,"Pathways in cancer",31,28,0.304040048,0.000289436,0.003028737]
[29,"Drug metabolism - cytochrome P450",56,51,-0.509104085,0.000358295,0.003510664]
[30,"Retinol metabolism",36,30,-0.55224638,0.000359454,0.003510664]
[31,"Malaria",50,42,0.512519162,0.00044603,0.003763068]
[32,"Legionellosis",18,15,0.55456202,4.47828E-4,0.003763068]
[33,"Leishmaniasis",31,29,0.483324598,0.000453104,0.003763068]
[34,"Cell cycle",22,16,0.429593927,0.000469373,0.003763068]
[35,"Hepatitis C",23,18,0.38358642,0.000476872,0.003763068]
[36,"Alcoholism",48,38,0.354236031,0.000482975,0.003763068]
[37,"Wnt signaling pathway",19,15,0.360333179,0.000484379,0.003763068]
[38,"Chemokine signaling pathway",20,16,0.33640157,0.000488043,0.003763068]
[39,"MicroRNAs in cancer",24,21,0.356142523,0.00050226,0.003773391]
[40,"Staphylococcus aureus infection",61,52,0.476278923,0.000679964,0.004810982]
[41,"Pancreatic cancer",74,58,0.482037443,6.81663E-4,0.004810982]
[42,"Chagas disease (American trypanosomiasis)",97,82,0.415254308,0.000698487,0.004810982]
[43,"Measles",47,43,0.384734246,0.000706048,0.004810982]
[44,"MAPK signaling pathway",63,59,0.304790372,0.000771803,0.005139509]
[45,"Chemical carcinogenesis",29,29,-0.461806025,0.000892698,0.005703607]
[46,"Melanoma",25,23,0.460070463,0.000897062,0.005703607]
[47,"Colorectal cancer",47,41,0.466044397,0.000914913,0.005703607]
[48,"Butanoate metabolism",27,23,-0.589252445,1.104566E-3,0.006742452]
[49,"T cell receptor signaling pathway",39,33,0.419286669,1.156069E-3,0.006813953]
[50,"Th17 cell differentiation",30,23,0.406044536,1.162791E-3,0.006813953]
[51,"Rap1 signaling pathway",32,27,0.326480302,0.00123885,0.007005738]
[52,"Metabolism of xenobiotics by cytochrome P450",28,25,-0.473257666,1.243339E-3,0.007005738]
[53,"Maturity onset diabetes of the young",20,17,-0.579618554,0.00128866,0.0071241]
[54,"Olfactory transduction",30,25,-0.292121288,0.001403618,0.007615928]
[55,"Glycine, serine and threonine metabolism",19,16,-0.542876289,1.457992E-3,0.007767119]
[56,"Glioma",26,24,0.446276572,0.00158371,0.008286199]
[57,"Fat digestion and absorption",67,57,-0.522701424,1.631321E-3,0.008385564]
[58,"B cell receptor signaling pathway",42,30,0.446444249,0.001802614,0.009106308]
[59,"Viral myocarditis",22,16,0.460317387,0.002027941,0.010070959]
[60,"Bile secretion",17,17,-0.450104946,0.002319772,0.011328218]
[61,"Pathogenic Escherichia coli infection",66,27,0.465304564,2.466368E-3,0.011846651]
[62,"Rheumatoid arthritis",76,66,0.397492177,0.002757987,0.012810493]
[63,"RNA transport",72,62,0.37340461,0.002766252,0.012810493]
[64,"TNF signaling pathway",79,66,0.381492285,0.002800467,0.012810493]
[65,"Drug metabolism - other enzymes",27,24,-0.446432339,0.002841918,0.012810493]
[66,"Pertussis",116,95,0.417343458,0.002968037,0.013176283]
[67,"Lysosome",53,48,0.360729921,0.003063148,0.013395558]
[68,"Antigen processing and presentation",75,60,0.430637717,0.003145361,0.013552804]
[69,"Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate",79,62,0.639055672,3.239741E-3,0.01375716]
[70,"Influenza A",98,76,0.338311626,0.003363767,0.014079769]
[71,"Prostate cancer",31,28,0.399338619,0.003622368,0.014948646]
[72,"Bacterial invasion of epithelial cells",73,56,0.428838872,0.003830554,0.015588228]
[73,"Neuroactive ligand-receptor interaction",45,42,-0.286481211,0.003996803,0.016041961]
[74,"Cytokine-cytokine receptor interaction",105,54,0.275655759,0.004168838,0.016506345]
[75,"Cardiac muscle contraction",153,104,-0.418409912,0.004279601,0.016612096]
[76,"NOD-like receptor signaling pathway",165,95,0.319655661,0.004346776,0.016612096]
[77,"Porphyrin and chlorophyll metabolism",91,56,-0.533941172,0.004374772,0.016612096]
[78,"alpha-Linolenic acid metabolism",79,50,-0.568954733,0.004422333,0.016612096]
[79,"Endocrine resistance",31,24,0.390164977,0.004980756,0.018472931]
[80,"Breast cancer",45,25,0.325433417,0.005283381,0.019350384]
[81,"Toxoplasmosis",36,28,0.355298329,0.005552985,0.020086723]
[82,"Leukocyte transendothelial migration",134,66,0.351987521,0.006033883,0.021560093]
[83,"Dilated cardiomyopathy",45,28,-0.386145912,0.006160887,0.021744635]
[84,"Fructose and mannose metabolism",23,16,-0.528535994,6.233957E-3,0.021744635]
[85,"Complement and coagulation cascades",74,65,0.378180962,0.007061503,0.024341418]
[86,"Shigellosis",33,24,0.443473377,0.007640449,0.025725825]
[87,"Th1 and Th2 cell differentiation",47,31,0.376125611,7.697532E-3,0.025725825]
[88,"Neurotrophin signaling pathway",23,17,0.346054157,0.007726528,0.025725825]
[89,"Notch signaling pathway",41,29,0.462828418,0.008014248,0.026360774]
[90,"Hypertrophic cardiomyopathy (HCM)",54,38,-0.384204017,0.008097166,0.026360774]
[91,"Histidine metabolism",295,248,-0.558891772,0.008301051,0.026450495]
[92,"Non-small cell lung cancer",85,65,0.434047268,0.008305275,0.026450495]
[93,"Acute myeloid leukemia",232,207,0.416483025,0.0090212,0.02842163]
[94,"cGMP-PKG signaling pathway",206,182,-0.3324218,0.009496354,0.029432102]
[95,"Bladder cancer",188,175,0.47154406,0.009542832,0.029432102]
[96,"Pyruvate metabolism",166,137,-0.479230934,0.010248902,0.031280503]
[97,"mRNA surveillance pathway",212,187,0.401150043,0.010679391,0.032101274]
[98,"Axon guidance",294,271,0.297842456,0.010736945,0.032101274]
[99,"Renal cell carcinoma",190,163,0.422951528,0.011246064,0.033104467]
[100,"Insulin signaling pathway",100,87,-0.345300916,0.011298453,0.033104467]
[101,"Carbon metabolism",100,75,-0.357073257,0.011829096,0.034316091]
[102,"beta-Alanine metabolism",132,101,-0.500095124,0.013148283,0.037496412]
[103,"Arrhythmogenic right ventricular cardiomyopathy (ARVC)",99,81,-0.392195101,0.013181332,0.037496412]
[104,"RNA polymerase",119,94,0.51138499,0.014413627,0.040607623]
[105,"Protein digestion and absorption",148,127,0.343865039,0.014794267,0.04128305]
[106,"Pancreatic secretion",338,322,-0.354891417,0.015392688,0.042547714]
[107,"Apoptosis - multiple species",124,101,0.489726724,0.015611258,0.042748584]
[108,"Basal cell carcinoma",125,98,0.390428123,0.015772871,0.042791214]
[109,"Fc gamma R-mediated phagocytosis",72,68,0.364855637,0.01681436,0.045198235]
[110,"TGF-beta signaling pathway",137,91,0.352611735,0.016976371,0.045218878]
[111,"FoxO signaling pathway",34,22,0.328067095,0.017366815,0.045842134]
[112,"Necroptosis",32,21,0.310798139,0.017602284,0.046048831]
[113,"Pentose phosphate pathway",65,50,-0.502349142,0.018954729,0.049148104]